Clinical Trial Update: Clinical Study to Investigate the Safety and Pharmacokinetics of SK3530 Tablet in Renal Impaired Male Patients [Phase 1]

View source ↗

Summary

Phase 1 study completed evaluating the safety and pharmacokinetics of SK3530 tablets in male patients with renal impairment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• SK3530 Tablet (SK3530)

Snippet

Sponsor: Asan Medical Center | Conditions: Renal Insufficiency, Kidney Diseases | Phase 1 | Status: COMPLETED